Patient Guide: 5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 80 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07124884
Status: NOT_YET_RECRUITING
Condition: Colorectal Carcinoma, KRAS G12C Mutation, Unresectable Colorectal Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 80 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Angers,
  • Annecy,
  • Antony,
  • • And 77 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily